The global Toxic Epidermal Necrolysis (TEN) market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Toxic Epidermal Necrolysis (TEN) market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Toxic Epidermal Necrolysis (TEN) market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Toxic Epidermal Necrolysis (TEN) market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Neonatal Patients Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Toxic Epidermal Necrolysis (TEN) include Mlnlycke Health Care, maxill inc, Cadila Pharmaceuticals, BD, Schulke India Pvt. Ltd, Smith & Nephew, Basic Pharma Life Science P Ltd., PSK Pharma and Avrio Health L.P., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Toxic epidermal necrolysis (TEN) is a rare and serious skin condition. Often, its caused by an adverse reaction to medication like anticonvulsants or antibiotics.The main symptom is severe skin peeling and blistering. The peeling progresses quickly, resulting in large raw areas that may ooze or weep. It also affects the mucous membranes, including the mouth, throat, eyes, and genital region.
This report aims to provide a comprehensive presentation of the global market for Toxic Epidermal Necrolysis (TEN), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Toxic Epidermal Necrolysis (TEN). This report contains market size and forecasts of Toxic Epidermal Necrolysis (TEN) in global, including the following market information:
Global Toxic Epidermal Necrolysis (TEN) Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Toxic Epidermal Necrolysis (TEN) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Toxic Epidermal Necrolysis (TEN) Market, by Disease Type, 2019-2024, 2025-2030 ($ millions)
Global Toxic Epidermal Necrolysis (TEN) Market Segment Percentages, by Disease Type, 2023 (%)
- Neonatal Patients
- Adolescent Patients
- Adult Patients
Global Toxic Epidermal Necrolysis (TEN) Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Toxic Epidermal Necrolysis (TEN) Market Segment Percentages, by Application, 2023 (%)
- Hospital
- Diagnostic Center
- Others
Global Toxic Epidermal Necrolysis (TEN) Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Toxic Epidermal Necrolysis (TEN) Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Toxic Epidermal Necrolysis (TEN) revenues in global market, 2019-2024 (estimated), ($ millions)
- Key companies Toxic Epidermal Necrolysis (TEN) revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Mlnlycke Health Care
- maxill inc
- Cadila Pharmaceuticals
- BD
- Schulke India Pvt. Ltd
- Smith & Nephew
- Basic Pharma Life Science P Ltd.
- PSK Pharma
- Avrio Health L.P.
- 3M
- Biesterfeld AG
- Vesismin Health
- Mylan N.V.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Toxic Epidermal Necrolysis (TEN), market overview.
Chapter 2: Global Toxic Epidermal Necrolysis (TEN) market size in revenue.
Chapter 3: Detailed analysis of Toxic Epidermal Necrolysis (TEN) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by disease type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Toxic Epidermal Necrolysis (TEN) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
